|
|
 |
Your account's overdrawn omeprazole in pregnancy third trimester Aegis Capital Corp began coverage of the biotechnologycompany with a "buy" rating, saying preliminary data of itsbladder and lung cancer study could be out later in the year andpositive outcomes could make it a prime acquisition candidate.
2021-2-4 2:37:23 |
|
|
|
